DPX - RSV is a small, B - cell epitope
peptide vaccine targeting the unmet medical needs in respiratory syncytial virus (RSV).
Not exact matches
Another possible application for the new machine is generating
peptides that could be used as personalized cancer
vaccines targeting unique proteins found in individual patients» tumors.
The albumin -
targeted vaccines provoked immune responses five to 10 times stronger than those generated by the
peptide antigens alone.
These same models are used to develop new anti-cancer
vaccines based on long
peptide or DNA vaccination
targeting the antigen to antigen presenting cells.